HSBC/CALL/ABBOTT LABORATORIES/100/0.1/20.06.24 Stock

Warrant

DE000HG4AN06

Real-time BOERSE MUENCHEN 07:35:25 2024-06-05 am EDT
0.37 EUR +5.71% Intraday chart for HSBC/CALL/ABBOTT LABORATORIES/100/0.1/20.06.24
Current month+29.63%
1 month-50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-05 0.37 +5.71%
24-06-04 0.35 -2.78%
24-06-03 0.36 +33.33%
24-05-31 0.27 -6.90%
24-05-30 0.29 +20.83%

Real-time BOERSE MUENCHEN

Last update June 05, 2024 at 07:35 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer HSBC
WKN HG4AN0
ISINDE000HG4AN06
Date issued 2022-06-23
Strike 100 $
Maturity 2024-06-20 (16 Days)
Parity 10 : 1
Emission price 1.98
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.54
Lowest since issue 0.21
Spread 0.05
Spread %12.50%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.4 USD
Average target price
125.4 USD
Spread / Average Target
+21.22%
Consensus